Literature DB >> 1609087

Epi- and metaphyseal changes in children caused by administration of bisphosphonates.

E L van Persijn van Meerten1, H M Kroon, S E Papapoulos.   

Abstract

Nitrogen-containing bisphosphonates (NCBs) are potent inhibitors of bone resorption and are used in the treatment of adults with various skeletal disorders. Little is known about their effects on the growing skeleton. The authors retrospectively studied the skeletal radiographs obtained in nine children before, during, and after NCB administration. Bandlike metaphyseal sclerosis and concentric epi- and apophyseal sclerosis developed in all patients. The extent of sclerosis depended on the duration of treatment and was related to local, and probably general, skeletal growth activity. In the maturing spine, NCBs caused a "picture-frame" or "bone-within-bone" appearance, depending on continuation or cessation of administration. In addition, metaphyseal undertubulation of long bones was noted in five patients. After discontinuation of bisphosphonate treatment and/or closure of the growth plates, the degree of sclerosis decreased, and sclerosis tended to disappear, indicating that this is a reversible phenomenon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1609087     DOI: 10.1148/radiology.184.1.1609087

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors:  Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal:  Pediatr Radiol       Date:  2010-10-30

Review 2.  Biphosphonates.

Authors:  J Allgrove
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

3.  "Zebra Stripe" Sign and "Bone in Bone" Sign in Cyclical Bisphosphonate Therapy.

Authors:  Partha Pratim Chakraborty; Sugata Narayan Biswas; Shinjan Patra; Gouranga Santra
Journal:  J Clin Diagn Res       Date:  2017-02-01

4.  Approach to the child with fractures.

Authors:  Alison M Boyce; Rachel I Gafni
Journal:  J Clin Endocrinol Metab       Date:  2011-07       Impact factor: 5.958

5.  Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome.

Authors:  Alessandro Corsi; Ernesto Ippolito; Pamela G Robey; Mara Riminucci; Alan Boyde
Journal:  Skeletal Radiol       Date:  2017-06-28       Impact factor: 2.199

6.  Denosumab treatment for fibrous dysplasia.

Authors:  Alison M Boyce; William H Chong; Jack Yao; Rachel I Gafni; Marilyn H Kelly; Christine E Chamberlain; Carol Bassim; Natasha Cherman; Michelle Ellsworth; Josephine Z Kasa-Vubu; Frances A Farley; Alfredo A Molinolo; Nisan Bhattacharyya; Michael T Collins
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

7.  Intravenous pamidronate in juvenile osteoporosis.

Authors:  N J Shaw; C M Boivin; N J Crabtree
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

8.  Metaphyseal bands in osteogenesis imperfecta.

Authors:  Ss Suresh; John K Thomas
Journal:  Indian J Radiol Imaging       Date:  2010-02

Review 9.  Use of bisphosphonates for the treatment of stress fractures in athletes.

Authors:  Yosuke Shima; Lars Engebretsen; Junji Iwasa; Katsuhiko Kitaoka; Katsuro Tomita
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-12-02       Impact factor: 4.342

Review 10.  Bisphosphonate treatment for children with disabling conditions.

Authors:  Alison M Boyce; Laura L Tosi; Scott M Paul
Journal:  PM R       Date:  2013-12-22       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.